KNB
RPRX icon

KHAZANAH NASIONAL BERHAD’s Royalty Pharma RPRX Stock Holding History

KHAZANAH NASIONAL BERHAD’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,501
Closed -$216K – 161
2026
Q1 		$216K Sell
4,501
-4,757
-51% -$208K 0.01% 127
2025
Q4 		$358K Buy
+9,258
New +$353K 0.02% 88

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KHAZANAH NASIONAL BERHAD's RPRX Position: Q2 2026 in Review

KHAZANAH NASIONAL BERHAD sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 4,501 shares — an estimated $216K sold.

KHAZANAH NASIONAL BERHAD first reported a position in RPRX in Q4 2025 and held it in 2 quarters. The position peaked at $358K in Q4 2025. 648 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • KHAZANAH NASIONAL BERHAD reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • KHAZANAH NASIONAL BERHAD sold 4,501 Royalty Pharma shares in Q2 2026, an estimated $216K.
  • KHAZANAH NASIONAL BERHAD first reported a position in Royalty Pharma in Q4 2025 and held it in 2 quarters.
  • KHAZANAH NASIONAL BERHAD's Royalty Pharma position peaked at $358K in Q4 2025.
  • 648 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on KHAZANAH NASIONAL BERHAD's 13F filing for Q2 2026, filed 20 Oct 2026.